Long-term Therapy for Spasmodic Dysphonia
Open Access
- 1 April 2001
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 127 (4) , 393-399
- https://doi.org/10.1001/archotol.127.4.393
Abstract
DYSTONIAS are disorders of central motor processing that lead to abnormal tonicity of muscles and thus dyskinetic movements or uncontrolled spasms. These movements can be slow and sustained or rapid and uncoordinated. Focal dystonias involve only one particular region of the body, whereas multifocal dystonias, as the name implies, involve several regions or muscle groups. In 1871, Traube1 first described the focal laryngeal dystonia known as spasmodic dysphonia (SD).Keywords
This publication has 6 references indexed in Scilit:
- Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patientsThe Laryngoscope, 1998
- A, comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphoniaPublished by Springer Nature ,1993
- Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: Acoustic, aerodynamic, and videoendoscopic findingsThe Laryngoscope, 1992
- Double‐blind controlled study of botulinum toxin in adductor spasmodic dysphoniaThe Laryngoscope, 1991
- Adductor Spastic Dysphonia: Heterogeneity of Physiologic and Phonatory CharacteristicsAnnals of Otology, Rhinology & Laryngology, 1988
- Maximum Phonation Time and Air Usage During PhonationFolia Phoniatrica et Logopaedica, 1968